Patient Preferences for Ulcerative Colitis Treatment in the Middle East Region: A Discrete-Choice Experiment
Background and Aims: Treatments for ulcerative colitis (UC) differ in safety, efficacy, and route of administration; patient preferences for treatment attributes should be considered in treatment decisions. No study to date has explored patient preferences for moderate-to-severe UC treatment in Midd...
Main Authors: | Othman AlHarbi, Niazy Abu Farsakh, Sameer Al-Awadhi, Talal Al-Taweel, Inas Mikhail, Faisal Batwa, Khalil Bedran, Dilara Balkan, Levent Mert Gunay, Joseph C. Cappelleri, Marco Boeri, Colton Leach, Sara Habjoka, Mahmoud Mosli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Gastro Hep Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572323001619 |
Similar Items
-
The missing “C”: Crohn's, colitis and coping
by: Turki AlAmeel, et al.
Published: (2019-01-01) -
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East
by: Gaurav B. Nigam, et al.
Published: (2024-02-01) -
Correlation between physician- and patient-directed disease assessments in ulcerative colitis patients from Saudi Arabia and Kuwait: Data from ICONIC
by: Othman Al Harbi, et al.
Published: (2023-01-01) -
Patient and physician preferences for ulcerative colitis treatments in the United States
by: Boeri M, et al.
Published: (2019-06-01) -
Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
by: Sameer Al Awadhi, et al.
Published: (2023-11-01)